AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

A new position paper by the American Academy of Sleep Medicine highlights the serious health risks associated with sleepiness, a condition affecting one-third of U.S. adults. Excessive daytime ...

Excessive daytime napping was significantly and independently associated with depressive symptoms among patients with bipolar disorder.

Only one reliable treatment for the sexually transmitted infection still exists, because the bacteria that cause it have ...

Topline results were announced from a phase 3 trial evaluating solriamfetol for the treatment of major depressive disorder (MDD) with and without severe excessive daytime sleepiness (EDS).

One-third of U.S. adults have self-reported experiencing excessive sleepiness, which research shows is linked to higher risks of cognitive and functional impairment, workplace accidents ...

“From drowsy driving crashes to workplace errors and long-term health risks, the effects of excessive daytime sleepiness impact individuals and society every day,” Olson said in a statement ...

“Sleepiness is a serious health concern with wide-reaching consequences,” said AASM President Dr. Eric Olson, a pulmonologist and sleep medicine specialist at the Mayo Clinic in Rochester, Minnesota. ...